Joel Theisen argues for an update of HIPAA that acknowledges an advanced technology landscape and scales back healthcare data silos.
HIPAA reform should protect patients, scale back silos around medical data Read More »
Upstaza is the first targeted therapy for aromatic L-amino acid decarboxylase (AADC) deficiency. PTC expects to submit a Biologics License Application to the FDA in the first half of 2023.
NICE Backs PTC’s Gene Therapy for Ultra-Rare Pediatric Disease Read More »
Analysts point to a missed secondary endpoint and cardiovascular risks that may delay FDA approval as possible reasons for the unexpected drop in Karuna’s stock following the data reveal.
Latest Data for Karuna’s Schizophrenia Drug Spark Investor Concern Read More »
En solo unas pocas horas de observación con el telescopio espacial James Webb, unos astrónomos han descubierto una atmósfera sorprendentemente dinámica en un planeta que, pese a no tener ninguna estrella cerca, está muy caliente. El hallazgo es obra del eq …
Mucho calor y atmósfera muy dinámica en un planeta sin ninguna estrella cerca Read More »
Hace ocho años, comenzó a circular la hipótesis de que el nitrato, un tipo de compuesto común en fertilizantes y desechos animales, puede ayudar a transportar uranio natural del subsuelo a las aguas subterráneas. Ahora, una nueva investigación ha examinado a …
¿Radiactividad en el agua por culpa del nitrato de fertilizantes? Read More »
In a double data drop Thursday, AbbVie touted two clinical trial wins, for Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus.
AbbVie Clinches Back-to-Back Clinical Wins in Ulcerative Colitis, Lupus Read More »
PTC Therapeutics, Inc. (NASDAQ: PTCT ). Stuart Peltz , Ph.D., founding Chief Executive Officer (CEO) of PTC Therapeutics announced today that he is stepping down after 25 years.
SQI Diagnostics Inc. announces that certain insiders of the Company, who are also control persons of the Company and collectively own, or exercise control or direction over, an aggregate of 75% of the issued and outstanding common shares.
SQI DIAGNOSTICS ANNOUNCES PROPOSED INSIDER SALES AND WARRANT EXERCISES TO FUND COMPANY Read More »
INVO Bioscience, Inc. today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor to purchase 3,680,000 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules.
Orion Health, a global leader in population health software, is strengthening its position in North America with new technology and the appointment of James Rice as Executive Vice President for North America.
Orion Health strengthens North American operations with new technology and leadership Read More »
